نتائج البحث - "E. Rizova"

1

Disease burden and treatment history among adults with atopic dermatitis receiving systemic therapy

المؤلفون: Ana Giménez-Arnau, E. Rizova, Shyamalie Jayawardena, Tove Agner, Zafer E. Ozturk, Åke Svensson, Marius Ardeleanu, Annalisa Patrizi, Petr Arenberger, Laurent Eckert, Marie L A Schuttelaar, Marjolein S. de Bruin-Weller, Andrew Pink, Silvia Ferrucci, Audrey Nosbaum, Pierre Paul Roquet-Gravy

المساهمون: Public Health Research (PHR)

المصدر: Journal of dermatological treatment, 32(2), 164-173. Taylor & Francis Ltd
Bruin-Weller, M D, Pink, A E, Patrizi, A, Gimenez-Arnau, A M, Agner, T, Roquet-Gravy, P P, Ferrucci, S M, Arenberger, P, Svensson, A, Schuttelaar, M L A, Nosbaum, A, Jayawardena, S, Rizova, E, Ardeleanu, M, Eckert, L & Ozturk, Z E 2021, ' Disease burden and treatment history among adults with atopic dermatitis receiving systemic therapy : baseline characteristics of participants on the EUROSTAD prospective observational study ', Journal of Dermatological Treatment, vol. 32, no. 2, pp. 164-173 . https://doi.org/10.1080/09546634.2020.1866741

مصطلحات موضوعية: Adult, Male, Pediatrics, medicine.medical_specialty, Adolescent, Dermatology, Comorbidity, Systemic therapy, Severity of Illness Index, Dermatitis, Atopic, systemic therapy, 030207 dermatology & venereal diseases, 03 medical and health sciences, Young Adult, 0302 clinical medicine, Quality of life (healthcare), Cost of Illness, Adrenal Cortex Hormones, medicine, Prevalence, Humans, Prospective Studies, Treatment history, Health policy, Disease burden, Aged, Atopic dermatitis, 030203 arthritis & rheumatology, Aged, 80 and over, business.industry, Middle Aged, medicine.disease, body regions, quality of life, patient-reported outcomes, Baseline characteristics, Cyclosporine, Observational study, Female, Dermatologic Agents, business

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2c604dff4c01449442d87fe0491e8253
https://doi.org/10.1080/09546634.2020.1866741

PDF full text from Publisher

2

Laboratory safety of dupilumab in moderate‐to‐severe atopic dermatitis: results from three phase III trials (LIBERTY AD SOLO 1, LIBERTY AD SOLO 2, LIBERTY AD CHRONOS)

المؤلفون: Lisa A. Beck, Ana B. Rossi, Faisal A. Khokhar, Marius Ardeleanu, N.M.H. Graham, E. Rizova, Zhen Chen, Yufang Lu, Eric L. Simpson, Gianluca Pirozzi, A. Wollenberg, Thomas Hultsch, Q. Chen, Brad Shumel, Andrew Blauvelt

المصدر: The British Journal of Dermatology

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5e08371ddab6c14d167a4a10631a0334
http://europepmc.org/articles/PMC7317598

View record at Wiley

3

Conjunctivitis in dupilumab clinical trials

المساهمون: Dermatology

المصدر: The British Journal of Dermatology
BRITISH JOURNAL OF DERMATOLOGY
British Journal of Dermatology, 181(3), 459-473. Wiley-Blackwell Publishing Ltd

مصطلحات موضوعية: Adult, medicine.medical_specialty, PERSISTENT ASTHMA, OCULAR COMPLICATIONS, Dermatology, Placebo, Antibodies, Monoclonal, Humanized, Severity of Illness Index, Dermatitis, Atopic, Placebos, 030207 dermatology & venereal diseases, 03 medical and health sciences, Young Adult, DOUBLE-BLIND, 0302 clinical medicine, Nasal Polyps, ATOPIC-DERMATITIS PATIENTS, Risk Factors, Severity of illness, medicine, Medicine and Health Sciences, Humans, Medical prescription, Sinusitis, 2-PHASE 3 TRIALS, Asthma, Randomized Controlled Trials as Topic, Rhinitis, PLACEBO, business.industry, Incidence (epidemiology), Incidence, Interleukin-4 Receptor alpha Subunit, Antibodies, Monoclonal, Atopic dermatitis, Eosinophilic Esophagitis, ADULTS, Original Articles, medicine.disease, Conjunctivitis, Dupilumab, Clinical Trial, PREVALENCE, Clinical trial, BARRIER FUNCTION, DRY EYE DISEASE, business

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::12cc04b8fb5e10e63158088861053bfc
http://europepmc.org/articles/PMC6850316

View record at Wiley

4

Dupilumab provides important clinical benefits to patients with atopic dermatitis who do not achieve clear or almost clear skin according to the Investigator's Global Assessment: a pooled analysis of data from two phase III trials

المؤلفون: Ana B. Rossi, Andrew Korotzer, Eric L. Simpson, Jonathan I. Silverberg, Bolanle Akinlade, E. Rizova, Jingdong Chao, Yufang Lu, Thomas Hultsch, Marius Ardeleanu, Sébastien Barbarot, Diamant Thaçi, N.M.H. Graham, Laurent Eckert, Zhen Chen, Gianluca Pirozzi, Jerry Bagel

المساهمون: Northwestern University Feinberg School of Medicine, Oregon Health & Science University, Regeneron Pharmaceuticals Inc., Universität zu Lübeck [Lübeck], Centre hospitalier universitaire de Nantes (CHU Nantes), Eczema Treatment Center of Central New Jersey, Partenaires INRAE, Sanofi, Sanofi Genzyme, Regeneron Pharmaceuticals

المصدر: The British Journal of Dermatology
British Journal of Dermatology
British Journal of Dermatology, Wiley, 2019, 181 (1), pp.80-87. ⟨10.1111/bjd.17791⟩
British Journal of Dermatology 1 (181), 80-87. (2019)

مصطلحات موضوعية: Adult, Male, medicine.medical_specialty, Injections, Subcutaneous, Eczema, Dermatology, Placebo, Antibodies, Monoclonal, Humanized, Severity of Illness Index, Eczema Area and Severity Index, Dermatitis, Atopic, Placebos, 030207 dermatology & venereal diseases, 03 medical and health sciences, 0302 clinical medicine, Double-Blind Method, Internal medicine, Post-hoc analysis, medicine, Humans, Skin, Dermatologie, Body surface area, business.industry, Antibodies, Monoclonal, Dermatology Life Quality Index, Atopic dermatitis, Original Articles, Middle Aged, medicine.disease, Dupilumab, Clinical Trial, 3. Good health, Clinical trial, Treatment Outcome, Quality of Life, Female, business, [SDV.MHEP.DERM]Life Sciences [q-bio]/Human health and pathology/Dermatology